Jinling Pharmaceutical announced that Chizhou Dongsheng Pharmaceutical Co., Ltd., a holding subsidiary of the company, recently received a notice of approval for the marketing application for the marketing of allolol hydrochloride chemical raw materials issued by the State Drug Administration. The API specifications are 1kg/bag and can be manufactured and sold in the domestic market after approval. Allolol hydrochloride is an alpha and beta blocker. The preparation is mainly used to treat diseases such as essential hypertension and angina pectoris. This approval is conducive to enriching the company's API product line. It will not have a significant impact on the company's current business performance. There is uncertainty about the future production and sales scale of this API.

Jinling Pharmaceutical announced that Chizhou Dongsheng Pharmaceutical Co., Ltd., a holding subsidiary of the company, recently received a notice of approval for the marketing application for the marketing of allolol hydrochloride chemical raw materials issued by the State Drug Administration. The API specifications are 1kg/bag and can be manufactured and sold in the domestic market after approval. Allolol hydrochloride is an alpha and beta blocker. The preparation is mainly used to treat diseases such as essential hypertension and angina pectoris. This approval is conducive to enriching the company's API product line. It will not have a significant impact on the company's current business performance. There is uncertainty about the future production and sales scale of this API.